AKT1 and hepatocellular carcinoma: Ech treatment of the hepatocellular carcinoma cell line HepG2 showed a concentration-dependent decrease in the expression of phosphorylated AKT and an increase in the expression of the cell cycle inhibitor p21 and the pro-apoptotic protein Bax [48].